Fate Therapeutics (FATE) Preferred Shares (2016 - 2026)

Fate Therapeutics (FATE) has 11 years of Preferred Shares data on file, last reported at $3000.0 in Q1 2026.

• Quarterly Preferred Shares changed 0.0% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $3000.0, changed 0.0% from the prior year.
• Preferred Shares was little changed at $3000.0 in Q1 2026, from $3000.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $3000.0 in Q1 2022 to a low of $3000.0 in Q1 2022.
• A 5-year average of $3000.0 and a median of $3000.0 in 2022 frame the typical range for Preferred Shares.
• The widest YoY moves for Preferred Shares: up 0.0% in 2022, down 0.0% in 2022.
• Tracing FATE's Preferred Shares over 5 years: stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
• The last three Preferred Shares figures came in at $3000.0 (Q1 2026), $3000.0 (Q4 2025), and $3000.0 (Q3 2025), per Business Quant data.